These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13489946)

  • 1. [Effect of monoethylamide (LAE) and diethylamide (LSD) of lysergic acid on behavior of mouse with imino-beta, beta-dipropionitrile induced circular movement].
    WIDLOCHER D; NAKAJIMA H; THUILLIER J
    C R Seances Soc Biol Fil; 1957; 151(4):668-70. PubMed ID: 13489946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the antagonistic psychopathological effects of lysergic acid monoethylamide (LAE-32) & methylphenylisopropylamine (pervitin)].
    CALLIERI B; RAVETTA M
    Rass Neuropsichiatr; 1957; 11(3-4):198-216. PubMed ID: 13506109
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
    Dolder PC; Liechti ME; Rentsch KM
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacopsychiatric study on a case of obsessive psychoneurosis; obsessive states during use of sympathomimetic drugs, amphetamine, LSD 25 & LAE 32.
    GIBERTI F; BREGORETTI L
    Sist Nerv; 1957; 9(4):275-88. PubMed ID: 13495598
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide].
    DELAY J; THUILLIER J; NAKAJIMA H; DURANDIN MC
    C R Seances Soc Biol Fil; 1959; 153(2):244-8. PubMed ID: 13663414
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959; 1():20-8. PubMed ID: 14405872
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of d-lysergic acid diethylamide and related compounds on melanophores].
    BERDE B; CERLETTI A
    Helv Physiol Pharmacol Acta; 1956; 14(3):325-33. PubMed ID: 13405353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis of structural analogs of LSD].
    Mravec D; Kalamár J; Proksa B; Horák F
    Cesk Farm; 1975 Apr; 24(3):110-5. PubMed ID: 1157105
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
    Niwaguchi T; Inoue T; Sakai T
    Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the pharmacology of D-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):114-30. PubMed ID: 13545891
    [No Abstract]   [Full Text] [Related]  

  • 16. [UML inhibits the action of LSD-25 on the conditions flight reflex in rats].
    Torre M; Fagiani MB; Torre E
    Minerva Psichiatr; 1982; 23(1):39-42. PubMed ID: 7098816
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.
    Ishii H; Hayashi M; Niwaguchi T; Nakahara Y
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds].
    Niwaguchi T; Nakahara Y; Ishii H
    Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uterotonic effect of d-lysergic acid cyclopentylamides in postpartum women].
    KOUTSKY J
    Cas Lek Cesk; 1958 Aug; 97(34):1067-9. PubMed ID: 13597012
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.